Jiangsu Aidea Pharmaceutical Co Ltd (688488) - Total Liabilities

Latest as of September 2025: CN¥762.97 Million CNY ≈ $111.65 Million USD

Based on the latest financial reports, Jiangsu Aidea Pharmaceutical Co Ltd (688488) has total liabilities worth CN¥762.97 Million CNY (≈ $111.65 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Jiangsu Aidea Pharmaceutical Co Ltd (688488) cash conversion ratio to assess how effectively this company generates cash.

Jiangsu Aidea Pharmaceutical Co Ltd - Total Liabilities Trend (2016–2024)

This chart illustrates how Jiangsu Aidea Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check 688488 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Jiangsu Aidea Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Jiangsu Aidea Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Green Cross Corp KO:006280	Korea	₩1.70 Trillion
Hiconics Drive Tech Co SHE:300048	China	CN¥3.06 Billion
Metsa Board Oyj B HE:METSB	Finland	€1.14 Billion
Magellan Aerospace Corporation TO:MAL	Canada	CA$340.00 Million
ARB Corporation Ltd AU:ARB	Australia	AU$134.90 Million
Huizhou China Eagle Electronic Technology Co Ltd SHE:002579	China	CN¥3.99 Billion
Prosiebensat 1 Media AG XETRA:PSM	Germany	€3.99 Billion
Anhui Xinlong Electrical Co Ltd SHE:002298	China	CN¥2.90 Billion

Liability Composition Analysis (2016–2024)

This chart breaks down Jiangsu Aidea Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 688488 company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.42	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.78	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.41	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Jiangsu Aidea Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Jiangsu Aidea Pharmaceutical Co Ltd (2016–2024)

The table below shows the annual total liabilities of Jiangsu Aidea Pharmaceutical Co Ltd from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥802.48 Million ≈ $117.43 Million	+29.22%
2023-12-31	CN¥621.03 Million ≈ $90.88 Million	+36.12%
2022-12-31	CN¥456.23 Million ≈ $66.76 Million	+265.52%
2021-12-31	CN¥124.82 Million ≈ $18.26 Million	+43.52%
2020-12-31	CN¥86.97 Million ≈ $12.73 Million	-61.30%
2019-12-31	CN¥224.74 Million ≈ $32.89 Million	+20.68%
2018-12-31	CN¥186.24 Million ≈ $27.25 Million	+28.31%
2017-12-31	CN¥145.14 Million ≈ $21.24 Million	+1.39%
2016-12-31	CN¥143.16 Million ≈ $20.95 Million	--

About Jiangsu Aidea Pharmaceutical Co Ltd

SHG:688488 China Biotechnology

Market Cap

$1.06 Billion

CN¥7.26 Billion CNY

Market Cap Rank

#8856 Global

#2336 in China

Share Price

CN¥17.26

Change (1 day)

-0.23%

52-Week Range

CN¥11.11 - CN¥22.16

All Time High

CN¥42.39